Perfuse Therapeutics

About Perfuse Therapeutics

Perfuse Therapeutics is a biotechnology company focused on developing therapies to improve blood flow to the retina, addressing ischemia-driven ocular diseases. Their first-in-class endothelin antagonist aims to enhance retinal perfusion to treat glaucoma and diabetic retinopathy. The company highlights leadership in ocular drug discovery, formulation, and development, and is based in South San Francisco, California.